The benefit of HER2-targeted therapies on overall survival of patients with metastatic HER2-positive breast cancer – a systematic review
Crossref DOI link: https://doi.org/10.1186/s13058-015-0648-2
Published Online: 2015-11-17
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mendes, Diogo
Alves, Carlos
Afonso, Noémia
Cardoso, Fátima
Passos-Coelho, José Luís
Costa, Luís
Andrade, Sofia
Batel-Marques, Francisco
License valid from 2015-11-17